BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 21355098)

  • 1. A comparative evaluation of amitriptyline and duloxetine in painful diabetic neuropathy: a randomized, double-blind, cross-over clinical trial.
    Kaur H; Hota D; Bhansali A; Dutta P; Bansal D; Chakrabarti A
    Diabetes Care; 2011 Apr; 34(4):818-22. PubMed ID: 21355098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized double-blind study comparing the efficacy and safety of lamotrigine and amitriptyline in painful diabetic neuropathy.
    Jose VM; Bhansali A; Hota D; Pandhi P
    Diabet Med; 2007 Apr; 24(4):377-83. PubMed ID: 17335465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized, placebo-controlled comparison of amitriptyline, duloxetine, and pregabalin in patients with chronic diabetic peripheral neuropathic pain: impact on pain, polysomnographic sleep, daytime functioning, and quality of life.
    Boyle J; Eriksson ME; Gribble L; Gouni R; Johnsen S; Coppini DV; Kerr D
    Diabetes Care; 2012 Dec; 35(12):2451-8. PubMed ID: 22991449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative efficacy and safety of six antidepressants and anticonvulsants in painful diabetic neuropathy: a network meta-analysis.
    Rudroju N; Bansal D; Talakokkula ST; Gudala K; Hota D; Bhansali A; Ghai B
    Pain Physician; 2013; 16(6):E705-14. PubMed ID: 24284851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amitriptyline vs. pregabalin in painful diabetic neuropathy: a randomized double blind clinical trial.
    Bansal D; Bhansali A; Hota D; Chakrabarti A; Dutta P
    Diabet Med; 2009 Oct; 26(10):1019-26. PubMed ID: 19900234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of low-dose naltrexone in painful diabetic neuropathy: A randomized, double-blind, active-control, crossover clinical trial.
    Srinivasan A; Dutta P; Bansal D; Chakrabarti A; Bhansali AK; Hota D
    J Diabetes; 2021 Oct; 13(10):770-778. PubMed ID: 34014028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial.
    Tesfaye S; Sloan G; Petrie J; White D; Bradburn M; Julious S; Rajbhandari S; Sharma S; Rayman G; Gouni R; Alam U; Cooper C; Loban A; Sutherland K; Glover R; Waterhouse S; Turton E; Horspool M; Gandhi R; Maguire D; Jude EB; Ahmed SH; Vas P; Hariman C; McDougall C; Devers M; Tsatlidis V; Johnson M; Rice ASC; Bouhassira D; Bennett DL; Selvarajah D;
    Lancet; 2022 Aug; 400(10353):680-690. PubMed ID: 36007534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison a amitriptyline and maprotiline in the treatment of painful polyneuropathy in diabetics and nondiabetics.
    Vrethem M; Boivie J; Arnqvist H; Holmgren H; Lindström T; Thorell LH
    Clin J Pain; 1997 Dec; 13(4):313-23. PubMed ID: 9430812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials.
    Sultan A; Gaskell H; Derry S; Moore RA
    BMC Neurol; 2008 Aug; 8():29. PubMed ID: 18673529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain.
    Morello CM; Leckband SG; Stoner CP; Moorhouse DF; Sahagian GA
    Arch Intern Med; 1999 Sep; 159(16):1931-7. PubMed ID: 10493324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duloxetine vs. placebo in patients with painful diabetic neuropathy.
    Goldstein DJ; Lu Y; Detke MJ; Lee TC; Iyengar S
    Pain; 2005 Jul; 116(1-2):109-18. PubMed ID: 15927394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized control trial of duloxetine and gabapentin in painful diabetic neuropathy.
    Khasbage S; Shukla R; Sharma P; Singh S
    J Diabetes; 2021 Jul; 13(7):532-541. PubMed ID: 33340245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An open-label 52-week clinical extension comparing duloxetine with routine care in patients with diabetic peripheral neuropathic pain.
    Wernicke JF; Wang F; Pritchett YL; Smith TR; Raskin J; D'Souza DN; Iyengar S; Chappell AS
    Pain Med; 2007 Sep; 8(6):503-13. PubMed ID: 17716324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder.
    Brannan SK; Mallinckrodt CH; Brown EB; Wohlreich MM; Watkin JG; Schatzberg AF
    J Psychiatr Res; 2005 Jan; 39(1):43-53. PubMed ID: 15504423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duloxetine in Painful Diabetic Neuropathy: A Systematic Review.
    Hossain SM; Hussain SM; Ekram AR
    Clin J Pain; 2016 Nov; 32(11):1005-1010. PubMed ID: 26710221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duloxetine versus routine care in the long-term management of diabetic peripheral neuropathic pain.
    Raskin J; Smith TR; Wong K; Pritchett YL; D'Souza DN; Iyengar S; Wernicke JF
    J Palliat Med; 2006 Feb; 9(1):29-40. PubMed ID: 16430342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain.
    Raskin J; Pritchett YL; Wang F; D'Souza DN; Waninger AL; Iyengar S; Wernicke JF
    Pain Med; 2005; 6(5):346-56. PubMed ID: 16266355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative double-blind randomized study on the effectiveness of Duloxetine and Gabapentin on painful diabetic peripheral polyneuropathy.
    Majdinasab N; Kaveyani H; Azizi M
    Drug Des Devel Ther; 2019; 13():1985-1992. PubMed ID: 31354243
    [No Abstract]   [Full Text] [Related]  

  • 19. Multicentre, double-blind, crossover trial to identify the Optimal Pathway for TreatIng neurOpathic paiN in Diabetes Mellitus (OPTION-DM): study protocol for a randomised controlled trial.
    Selvarajah D; Petrie J; White D; Julious S; Bortolami O; Cooper C; Bradburn M; Loban A; Bowler H; Swaby L; Sutherland K; Tesfaye S;
    Trials; 2018 Oct; 19(1):578. PubMed ID: 30348206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duloxetine: a review of its use in the treatment of generalized anxiety disorder.
    Carter NJ; McCormack PL
    CNS Drugs; 2009; 23(6):523-41. PubMed ID: 19480470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.